Valeant Pharmaceuticals
Why the world needs short sellers
In a market where so many have a vested interest in pumping up stock prices, short sellers serve as a necessary, if unwelcome, reality check
Canadian pharma giant’s major acquisition attempt derailed
Your top financial and economic news for Nov. 17
It’s jobs day in North America!
Your top financial and economic news for Nov. 7
Bad news for Canada: the commodity complex has crumbled
Your top financial and economic news for Nov. 5
It’s the Bank of Canada’s biggest day of the year
Your top financial and economic news for Oct. 22
Strategists warn of ‘the coming energy recession’
Your top financial and economic news for Oct. 20
Is the eurozone’s largest economy on the verge of a recession?
Your top financial and economic news for Oct. 9
Valeant Pharmaceuticals plans to bump up bid for Allergan
Your top financial and economic news for Oct. 8.
So how’s Canada’s labour market really doing?
Your top financial and economic news for Sept. 25
Obama administration looks to crack down on tax inversions
Your top financial and economic news for Sept. 23
Just how indebted are Canadian households?
Your top financial and economic news for Sept. 12.
The Morning Playbook: Bill Ackman takes Valeant-Allergan saga to another level
Your top financial news for Sept. 10